200,000+ products from a single source!

sales@angenechem.com

Home > Pyridines > 14222-60-7

14222-60-7

14222-60-7 | 4-Pyridinecarbothioamide, 2-propyl-

CAS No: 14222-60-7 Catalog No: AG001HZV MDL No:MFCD00464119

Product Description

Catalog Number:
AG001HZV
Chemical Name:
4-Pyridinecarbothioamide, 2-propyl-
CAS Number:
14222-60-7
Molecular Formula:
C9H12N2S
Molecular Weight:
180.2700
MDL Number:
MFCD00464119
IUPAC Name:
2-propylpyridine-4-carbothioamide
InChI:
InChI=1S/C9H12N2S/c1-2-3-8-6-7(9(10)12)4-5-11-8/h4-6H,2-3H2,1H3,(H2,10,12)
InChI Key:
VRDIULHPQTYCLN-UHFFFAOYSA-N
SMILES:
CCCc1cc(ccn1)C(=S)N
EC Number:
238-093-7
UNII:
76YOO33643
NSC Number:
758962

Properties

Complexity:
159  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
180.072g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
180.269g/mol
Monoisotopic Mass:
180.072g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
71A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  

Literature

Title Journal
Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice. International journal of antimicrobial agents 20140201
Troublesome Tuberculosis: A Case Report on Multi-focal Tuberculous Osteomyelitis in An Immunocompetent Patient. Journal of clinical medicine research 20120201
Pharmacotherapy for multidrug resistant tuberculosis. Journal of pharmacology & pharmacotherapeutics 20120101
International spread of MDR TB from Tugela Ferry, South Africa. Emerging infectious diseases 20111101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
[A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20100901
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microbial drug resistance (Larchmont, N.Y.) 20100301
Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs. European respiratory review : an official journal of the European Respiratory Society 20091201
Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20090901
[Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis]. Problemy tuberkuleza i boleznei legkikh 20090101
[Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study]. Zhonghua yi xue za zhi 20081230
Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project. Leprosy review 20081201
Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases. BMC infectious diseases 20080101
[Tuberculosis or sarcoidosis]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20080101
Mechanism of thioamide drug action against tuberculosis and leprosy. The Journal of experimental medicine 20070122
Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC ear, nose, and throat disorders 20070101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. The American journal of tropical medicine and hygiene 20060301
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20040301
New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. The Journal of antimicrobial chemotherapy 20040101
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. HIV clinical trials 20040101
Longitudinal study of tuberculosis outcomes among immunologically naive Aché natives of Paraguay. American journal of physical anthropology 20030601
[Effect of glutoxim in the combination with antitubercular agents of the second choice on the growth of drug resistant Mycobacteria tuberculosis in the cultured murine lung tissue]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101
Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrobial agents and chemotherapy 20011101
[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20011001
The Malta Project--a country freed itself of leprosy. A 27-year progress study (1972-1999) of the first successful eradication of leprosy. Chemotherapy 20010101
[Use of the antioxidant ionol to prevent damage to the heart from prolonged administration of antitubercular preparations]. Biulleten' eksperimental'noi biologii i meditsiny 19831001

© 2019 Angene International Limited. All rights Reserved.